Viking Therapeutics Stock: Prepping For A Critical 2026 (NASDAQ:VKTX)

Core Insights - The article discusses the author's investment strategy and focus on Viking Therapeutics (VKTX), highlighting its potential as a long-term investment in the biotech sector [1]. Group 1: Investment Strategy - The author conducts an annual review of their portfolios, including top investment ideas from the Compounding Healthcare group [1]. - The focus is on innovative companies that are developing breakthrough therapies and pharmaceuticals, particularly those with catalysts for potential acquisitions [1]. Group 2: Company Overview - Viking Therapeutics is identified as one of the author's longest-standing investments, indicating confidence in its future performance [1]. - The author emphasizes a passion for biotech and life-saving therapies, stemming from years of experience in the medical field [1].